Based on 1 analyst offering 12 month price targets for Endra Life Sciences Inc
Min Forecast
$30.00+599.3%
Avg Forecast
$30.00+599.3%
Max Forecast
$30.00+599.3%
Should I buy or sell NDRA stock?
Based on 1 analyst offering ratings for Endra Life Sciences Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although NDRA's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates NDRA as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More
Be the first to know when Wall Street analysts revise their NDRA stock forecasts and price targets.
Is Endra Life Sciences Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: NDRA) stock is to Buy NDRA stock.
Out of 1 analyst, 0 (0%) are recommending NDRA as a Strong Buy, 1 (100%) are recommending NDRA as a Buy, 0 (0%) are recommending NDRA as a Hold, 0 (0%) are recommending NDRA as a Sell, and 0 (0%) are recommending NDRA as a Strong Sell.
What is NDRA's earnings growth forecast for 2026-2026?
(NASDAQ: NDRA) Endra Life Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Endra Life Sciences's earnings in 2026 is -$8,007,205.
In 2026, NDRA is forecast to generate -$5,496,737 in earnings, with the lowest earnings forecast at -$5,281,178 and the highest earnings forecast at -$5,658,405.
What is NDRA's revenue growth forecast for 2026-2026?
(NASDAQ: NDRA) Endra Life Sciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Endra Life Sciences's revenue in 2026 is $0.
In 2026, NDRA is forecast to generate $356,931 in revenue, with the lowest revenue forecast at $342,934 and the highest revenue forecast at $367,429.
What is NDRA's forecast return on assets (ROA) for 2026-2026?
(NASDAQ: NDRA) forecast ROA is -279.86%, which is lower than the forecast US Diagnostics & Research industry average of 9.74%.
What is NDRA's Price Target?
According to 1 Wall Street analyst that have issued a 1 year NDRA price target, the average NDRA price target is $30.00, with the highest NDRA stock price forecast at $30.00 and the lowest NDRA stock price forecast at $30.00.
The Wall Street analyst predicted that Endra Life Sciences's share price could reach $30.00 by Dec 8, 2026. The average Endra Life Sciences stock price prediction forecasts a potential upside of 599.3% from the current NDRA share price of $4.29.
What is NDRA's Earnings Per Share (EPS) forecast for 2026-2026?
(NASDAQ: NDRA) Endra Life Sciences's current Earnings Per Share (EPS) is $19.53. In 2026, NDRA's EPS is forecast to hit -$4.71 (min: -$4.53, max: -$4.85).
What is NDRA's forecast return on equity (ROE) for 2026-2026?
(NASDAQ: NDRA) forecast ROE is -3,207.34%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.